アリピプラゾールへの暴露反応分析 月1回 双極性I型障害と診断された患者
Xiaofeng Wang1, Luann Phillips2, Matthew Harlin3
1Pharmacometrics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Clinical pharmacology in drug development
|August 22, 2025
まとめ
アリピプラゾルの月1回の維持療法は,二極性障害の再発リスクを下げます. 95 ng/ mLの濃度は,気分エピソードの再発の有意な減少と関連しています.
科学分野:
- 薬理学について
- 精神科
- 臨床薬局
背景:
- アリピプラゾルは,月1回 (AOM) は,双極性障害 (BP- I) の維持用単体療法に示されています.
- 薬物曝露と治療結果の関係を理解することは,治療の最適化に不可欠です.
研究 の 目的:
- BP- I患者におけるAOMの集団製薬モデルを検証する.
- BP- Iにおける気分エピソードの再発に対するアリピプラゾール暴露の影響を評価するために,曝露-反応モデルを開発する.
主な方法:
- BP- I患者のデータを用いて集団の薬動学モデルを検証した.
- アリピプラゾルの暴露データを生成した.
- 再発リスクを分析するために連続的およびカテゴリ的モデルを使用した.
主要な成果:
- アリピプラゾールの高露出は,気分エピソードの再発のリスクの減少と関連していました.
- 血濃度が1ng/ ml上昇すると,再発リスクは0. 34%減少した.
- 血濃度95ng/ mlは,再発までの時間を有意に予測し,リスクを36%減少させた.
結論:
- アリピプラゾルの血濃度は,AOMのBP- I患者における再発の主要な予測因子である.
- AOMによるメンテナンス療法は,気分エピソードを予防するために重要です.
- BP-Iには95ng/mLの値が重要で,統合失調症よりも小さい効果を示しています.
関連する概念動画
01:30Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
01:24Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:28Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454